Oliver T. Wolf, Ragnar Preut, Dirk H. Hellhammer, Brigitte M. Kudielka, Thomas H. Schürmeyer, and Clemens Kirschbaum



Similar documents
Endogenous Estradiol and Testosterone Levels Are Associated with Cognitive Performance in Older Women and Men

Historical Basis for Concern

Prevalence Diagnosis and Treatment of Hypogonadism in Primary Care Practice by Culley C. Carson III, MD, Boston University Medical Campus

Testosterone for women, who when and how much?

Testosterone levels as modi ers of psychometric g

Testosterone. Testosterone For Women

Aging Well - Part V. Hormone Modulation -- Growth Hormone and Testosterone

THE ROLE OF PERFORMANCE IN THE STRESS RE-APPRAISAL PROCESS

COULD IT BE LOW TESTOSTERONE?

Sex Hormone Testing by Mass Spectrometry

Effects of Testosterone on Cognitive and Brain Aging in Elderly Men

Hormone Restoration: Is It Right for You? Patricia A. Stafford, M.D. Founder, Wellness ReSolutions

F T HERAPEUTICS. Testosterone and Andropause: The Feasibility of Testosterone Replacement Therapy in Elderly Men

Hypogonadism and Testosterone Replacement in Men with HIV

Testosterone; What s all the hype? KRISTEN WYRICK, LTCOL,USAFR, MC USUHS, FAMILY MEDICINE JOINT BASE LANGLEY-EUSTIS

testosterone_pellet_implantation_for_androgen_deficiency_in_men 10/2015 N/A 11/ /2015 This policy is not effective until December 30, 2015

Prevalence and Characteristics of Low Serum Testosterone Levels in Men with Type 2 Diabetes Mellitus Naïve to Injectable Therapy

Effects of the Menstrual Cycle on Verbal Working Memory in Young Women

Testosterone Treatment in Older Men

TESTOSTERONE The Future?

Testosterone Therapy for Women

Neal Rouzier responds to the JAMA article on Men and Testosterone

Chemobrain. Halle C.F. Moore, MD The Cleveland Clinic October 3, 2015

The relationship of male testosterone to components of mental rotation

February 25, Dear Dr. Hamburg:

Presenting Genital Symptoms and Physical Signs of Vaginal Atrophy

The relationship between stress induced cortisol levels and memory differs between men and women

The Effects of Moderate Aerobic Exercise on Memory Retention and Recall

Frequently Asked Questions

Testosterone safety and the prostate

FACT SHEET TESTETROL, A NOVEL ORALLY BIOACTIVE ANDROGEN

Shira Miller, M.D. Los Angeles, CA The Compounding Pharmacy of Beverly Hills Beverly Hills Public Library

Use Of Testosterone In Men With Prostate Cancer. Traditional view: T is dangerous for PCa

IBADAN STUDY OF AGEING (ISA): RATIONALE AND METHODS. Oye Gureje Professor of Psychiatry University of Ibadan Nigeria

Calcium. Table 1: Difference between method means in percent

Environmental modifiers: Prospects for rehabilitation in Huntington s disease

February 1, 2014 RESTORING STRENGTH AND VITALITY THROUGH HORMONES FACTS, FANTASIES, POSSIBILITIES, AND PITFALLS

Summary chapter 2 chapter 2

When are the physiological reactions unhealthy? Helene Garde National Research Centre for the Working Environment

THE DEPRESSION RESEARCH CLINIC Department of Psychiatry and Behavioral Sciences Stanford University, School of Medicine

Treatment of Metastatic Breast Cancer: Endocrine Therapies. Robert W. Carlson, M.D. Professor of Medicine Stanford University

Sponsor. Novartis Generic Drug Name. Vildagliptin. Therapeutic Area of Trial. Type 2 diabetes. Approved Indication. Investigational.

Summary of research findings

Hormone Replacement Therapy For Men Consultation Information. Round Rock Jollyville Westlake

Effects of estrogen and testosterone treatment on serotonin transporter binding in the brain of surgically postmenopausal women A PET study

Endocrine issues in FA SUSAN R. ROSE CINCINNATI CHILDREN S HOSPITAL MEDICAL CENTER

Participating in Alzheimer s Disease Clinical Trials and Studies

Bio-Identical Hormone FAQ s

Understanding the. Controversies of. testosterone replacement. therapy in hypogonadal men with prostate cancer. controversies surrounding

Primary Endpoints in Alzheimer s Dementia

Human Clinical Study for Free Testosterone & Muscle Mass Boosting

Protocol: Testosterone and cardiovasclar related events in men: a meta analysis of randomized controlled trials. Version: 1. Date: 5 th December 2011

Written Example for Research Question: How is caffeine consumption associated with memory?

Interpretive Report of WMS IV Testing

Promoting the Fountain of Youth: Low-T and Estrogen Deficiency

Using Testosterone in women

Continuity Clinic Educational Didactic. December 8 th December 12 th

Cognitive Rehabilitation for Executive Dysfunction in Parkinson s Disease

Michael L. DeVan, 1 Daniel D. Bankson, 2 and Jude M. Abadie 1. Abstract

Male New Patient Package

X/00/$03.00/0 Vol. 85, No. 1 The Journal of Clinical Endocrinology & Metabolism Copyright 2000 by The Endocrine Society

Testosterone in Old(er) Men

/04/ /0 Vol. 172, , August 2004 THE JOURNAL OF UROLOGY. Printed in U.S.A. Copyright 2004 by AMERICAN UROLOGICAL ASSOCIATION

Jill Malcolm, Karen Moir

ACUTE EFFECTS OF LORATADINE, DIPHENHYDRAMINE AND PLACEBO, ALONE AND WITH ALCOHOL, ON SKILLS PERFORMANCE

THE ROLE OF FREE TESTOSTERONE COMPARATIVE WITH TOTAL TESTOSTERONE IN MALE PATIENTS WITH ERECTILE DYSFUNCTION

Long Term Care Formulary HCD Anti-Dementia Drugs (e.g. donepezil, galantamine, rivastigmine, memantine)

t!k EUROPEAN MEDICINES AGENCY TESTOSTERONE UPDATE

Assessment of Cognition in Depression Treatment Studies. Philip D. Harvey, PhD University of Miami Miller School of Medicine

Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) Normative Data

The Women s Health Initiative: The Role of Hormonal Therapy in Disease Prevention

The WHI 12 Years Later: What Have We Learned about Postmenopausal HRT?

Cognitive abilities, androgen levels, and body mass index in 5-year-old children

Testosterone s. Effects on Anxiety: Androgens and Mood. EMAA 2006 Conference Paris: October 13-15th

Subcutaneous Testosterone-Anastrozole Therapy in Breast Cancer Survivors ASCO Breast Cancer Symposium Abstract 221 Rebecca L. Glaser M.D.

2. The prescribing clinician will register with the designated manufacturer.

Scientific conclusions and detailed explanation of the scientific grounds for the differences from the PRAC recommendation

WMS III to WMS IV: Rationale for Change

Androgens and CVD. Brandon Orr- Walker April 2014

Deficient testosterone levels in men above 45 years with major depressive disorder an age-matched case control study

TESTOSTERONE HALF-LIVES; METABOLISM AND DEGRADATION RATE

Us TOO University Presents: Estrogen Deficiency Side Effects Due to Androgen Deprivation Therapy

Diabetes Mellitus. Melissa Meredith M.D. Diabetes Mellitus

The ABC s and T s of Male Infertility

Varicocele: To Fix or Not to Fix? That is the Question. Edmund S. Sabanegh, MD

Integrating Physiotherapy and Occupational Therapy for Persons with Chronic Disease: Lessons Learned from Research in Primary Care

A list of FDA-approved testosterone products can be found by searching for testosterone at

CRITICALLY APPRAISED PAPER (CAP)


Profile of older drivers at higher accident risk in a complex traffic situation.

9/21/2015. Biological Lifestyle Factors in Adult Distance Education. Aims of my dissertation. Earlier findings and mechanisms

RESULTS. Group I: consists of 30 healthy pregnant women with uncomplicated pregnancy. Group II consists of 30 pregnant women with mild preeclampsia.

Ellen F. Binder, MD & Mark A. McDaniel, PhD Supported by NIH/NIA R01 AG Harvey A. Friedman Center for Aging

Surgery in Individuals Age 65+ Possible Risks. Possible Benefits. Potential Causes of POCD 11/24/2014. What is POCD?

Focus. Andropause: fact or fiction? Introduction. Johan Wilson is an Auckland GP KEY POINTS

Dealing with Cognitive Impairment in the Patient with Breast Cancer

Medical marijuana for pain and anxiety: A primer for methadone physicians. Meldon Kahan MD CPSO Methadone Prescribers Conference November 6, 2015

Jundishapur Journal Chronic Disease Care. 2013;2(3):41-46

The Rehab Professional s Role in Dining for Persons with Dementia. By: Bonnie Saunders PT, MPA, CDP

Talk to your doctor about low testosterone

Transcription:

Testosterone and Cognition in Elderly Men: A Single Testosterone Injection Blocks the Practice Effect in Verbal Fluency, but Has No Effect on Spatial or Verbal Memory Oliver T. Wolf, Ragnar Preut, Dirk H. Hellhammer, Brigitte M. Kudielka, Thomas H. Schürmeyer, and Clemens Kirschbaum Background: The relevance of the age-associated decline in testosterone for cognition in elderly men is still poorly understood. One hypothesis is that testosterone enhances spatial abilities, while it might impair verbal skills. Methods: Thirty elderly men received a single testosterone (250 mg testosterone enanthate) or placebo injection. Cognitive performance was tested before and 5 days after using spatial as well as verbal tests. Results: Five days after injection, testosterone and estradiol levels were still in the supraphysiologic range. In the verbal fluency task, the placebo group, but not the testosterone group, showed a practice effect. Therefore, the testosterone group performed significantly worse than the placebo group after. No effects of testosterone were observed in the other verbal and spatial tasks. Conclusions: The present finding, that testosterone blocks the practice effect in verbal fluency, partly supports the general idea that sex steroids modulate performance in tests with known gender differences. Moreover it demonstrates that these effects can occur rapidly. However, beneficial effects on spatial cognition or memory might need more time to develop and/or might only occur when a less pronounced testosterone increase is induced. Biol Psychiatry 2000;47: 650 654 2000 Society of Biological Psychiatry Key Words: Aging, cognition, humans, sex steroids, gender differences, replacement From the Center for Psychobiological and Psychosomatic Research, University of Trier, Trier, Germany (OTW, RP, DHH, BMK, THS, CK) and the Laboratory of Neuroendocrinology, Rockefeller University and the Neuroimaging Laboratory, Department of Psychiatry, NYU School of Medicine, New York, New York (OTW). Address reprint requests to Clemens Kirschbaum, Ph.D., Center for Psychobiological and Psychosomatic Research, University of Trier, Dietrichstraße 10-11, 54290 Trier, Germany. Received December 17, 1998; revised March 29, 1999; revised June 2, 1999; accepted June 3, 1999. Introduction In aging men, there is a decrease in total and free (unbound) testosterone levels (Vermeulen 1991). However, the relevance of this for cognitive impairments and other age-associated psychiatric problems is still poorly understood (Sternbach 1998). Estradiol replacement in women has resulted in conflicting findings (see for review: Haskell et al 1997; Rice et al 1997). At least studies by Sherwin et al suggest that estradiol specifically enhances verbal memory (Phillips and Sherwin 1992; Sherwin and Tulandi 1996), and studies from our laboratory indicate that this effect is already detectable after a short period (Wolf et al 1999). With respect to the effects of testosterone replacement in elderly men, Janowsky et al (1994) reported an increase in spatial cognition (block design subtest of the WAIS-R) after transdermal testosterone, whereas another study, which did not measure spatial cognition, failed to find effects on several other cognitive tests (Sih et al 1997). Recently, Cherrier et al (1998) reported preliminary evidence that testosterone increases spatial as well as verbal memory. The authors suggested that the effects on verbal memory might have been caused by the induced estradiol rise. The study by Janowsky et al (1994), as well as correlational observations in young women and men (reviewed in Kimura and Hampson 1994), clinical endocrine syndromes (reviewed in Hampson 1995), and transsexuals (Van Goozen et al 1995) seem to support the hypothesis that sex steroids especially influence cognitive domains where gender differences are apparent. Moreover, sex steroids might have enhancing as well as impairing properties depending on the domain tested, at least in women (Hampson 1995; Kimura and Hampson 1994). Testosterone may enhance spatial abilities and impair verbal skills, while the opposite seems to be the case for estradiol. However, whether similar effects occur in response to hormone replacement in elderly men is not established yet. 2000 Society of Biological Psychiatry 0006-3223/00/$20.00 PII S0006-3223(99)00145-6

Testosterone and Cognition in Elderly Men BIOL PSYCHIATRY 651 At least the preliminary data by Cherrier et al (1998) suggest a testosterone and/or estradiol effect on memory functions rather than specific effects on spatial or verbal skills with known gender differences. Given the lack of experimental studies in elderly men, the present study investigated the effects of a single testosterone depot injection on cognition tested 5 days later, at a time when blood levels of testosterone are still high. With this design, activational effects of this steroid and its metabolites could be tested. Methods and Materials Thirty healthy elderly men, who were recruited by newspaper advertisements, participated in the experiment. They underwent a comprehensive medical examination for past or current health problems including an ultrasonic screening for prostate abnormalities. Subjects with psychiatric, endocrine, cardiovascular, other chronic diseases, or those medicated with psychoactive drugs or glucocorticoids, were excluded from participation. Seventeen subjects (age: 68.7 1.9 years; body mass index (BMI): 25.5 0.6 kg/m 2 ; years of formal education: 10.4 0.9) received testosterone, 13 subjects (age: 67.1 1.8 years; BMI: 25.2 0.7 kg/m 2, years of formal education: 13.6 1.3) received placebo. The two groups did not differ significantly in these demographic variables (all p.05). In order to compare the hormone levels with a young control group, blood samples were also obtained from 23 young subjects (age: 25.5 0.5 years; BMI: 22.8 0.4 kg/m 2 ). The study was approved by the Ethics Committee of the University of Trier (Germany), and all subjects gave written informed consent. Procedure The study design was placebo controlled and double blind with testosterone or placebo. At baseline and 5 days after injection, subjects underwent a cognitive test battery (see Cognitive Tests ). Subjects received the injection 2 to 4 days after the baseline tests. Cognitive testing was performed in the early afternoon (between 2:30 and 4 PM). Hormonal Treatment Subjects received testosterone (250 mg testosterone enanthate; Rotexmedica GmbH Trittau, Germany) or placebo (saline) injection (IM). The used testosterone dose results in a strong testosterone rise in the first 24 hours after injection. Thereafter, the levels gradually decline and reach baseline levels approximately after 9 days. For the clinical of hypogonadal men, the injection is usually repeated every 3 weeks (information from the drug manufacturer). Biochemical Analyses both cognitive test sessions, blood samples were drawn in order to measure free testosterone, estradiol (RIAs, Biermann, Bad Nauheim, Germany), and total testosterone (RIA, IBL, Hamburg, Germany). Cognitive Tests Parallel versions of the following cognitive tests were used in a counterbalanced fashion. VERBAL FLUENCY. For 1 min subjects had to generate as many words as possible to a given first letter. Thereafter, a second letter was introduced with another 1 min test period. In general, women outscore men in this test (Horn 1983). SPATIAL MEMORY. Subjects were asked to memorize a route marked in a city map within 2 min. Immediate as well as delayed recall (after the mental rotation task, approximately 10 min later) was assessed by asking the subject to draw the learned route onto an unmarked map. The number of correctly chosen roads (maximum 31) was used as test score. In general, men outscore women in this test (Baeumler 1974). VERBAL MEMORY. Six word-pairs were read to the subject (one word per sec). Immediate as well as delayed recall (after the delayed spatial memory recall, 10 min later) was tested by presenting the first word of each pair as a cue. If the subject could not recall the correct word, the whole pair was read to him again. In both recall condition, each pair was tested twice. In general, no gender differences are observed in this task (Oswald and Fleischmann 1994). STROOP. For each card, the time needed to read or name the items was assessed and the difference between cards 3 and 2 was used as interference score. In general, no gender differences are observed with respect to this interference score (Oswald and Fleischmann 1994). MENTAL ROTATION. Five copies of a specific letter or number were presented on a piece of paper. Each item was rotated to different degrees from the normal horizontal position. In addition, one item in each line was flipped horizontally. This item had to be recognized and crossed out by the subject. The subject was given 2 min to complete as many items as possible. No normative data on the presence or absence of gender differences are provided in the test handbook (Horn 1983). Statistical Analyses Endocrine as well as cognitive data were analyzed with ANO- VAs. For all computed ANOVA models post hoc testing was done using Newman Keuls post hoc test. For all analyses, the significance level was.05. All results shown are the mean standard error of mean (sem). Results The elderly men had significantly lower levels of total testosterone, free testosterone, and estradiol at baseline.

652 BIOL PSYCHIATRY O.T. Wolf et al Table 1. Hormone Levels in Elderly Subjects Receiving Testosterone or Placebo Treatment and in Young Control Subjects (Mean SEM) Placebo Group Testosterone Young control subjects Before Before No Hormone Free testosterone 12.6 1.2 a 10.9 0.9 13.7 1.3 a 68.7 15.0 b 21.0 1.5 (pg/ml) Total testosterone 3.37 0.3 a 3.04 0.2 3.77 0.3 a 16.5 5.5 b 4.98 0.3 (ng/ml) Estradiol (pg/ml) 26.5 3.1 a 26.1 3.3 30.7 3.6 a 55.4 5.1 b 45.8 2.8 a p.05 compared to young control subjects. b p.05 compared to placebo group and to young control subjects. Testosterone led to a significant increase in all three hormones, which were higher compared to baseline, as well as higher than those from the placebo and the young control group, respectively (Table 1). The results of the cognitive tests are presented in Table 2. A significant group by interaction was observed in the verbal fluency task [F (1,28) 4.5; p.05]. Post hoc testing revealed that both groups did not differ from each other at baseline, however, the placebo group was significantly better than the testosterone group after (p.05). While the placebo group showed an increase in performance at the second test day (a practice effect; p.05), the testosterone group did not (p.24). The group main effect was not significant [F (1,28) 0.7; p.40], but the (time) main effect was [F (1,28) 20.1; p.05]. A practice effect was also evident in the Stroop [F (1,28) 15.7; p.05], as well as in the mental rotation task [F (1,28) 13.4, p.05]. In both tasks, however, this effect occurred in both groups ( main effect but no by group interaction). Moreover, the placebo group was significantly better than the testosterone group in the mental rotation task at baseline and after [F (1,28) 7.7; p.05], demonstrating baseline differences between the two groups in this test. Identical results were obtained for all ANOVAs described using years of formal education as a covariate in an ANCOVA model. Discussion A single testosterone injection resulting in supraphysiologic hormone levels had no beneficial effects on the five cognitive tests used in this study. It blocked the practice Table 2. Cognitive Performance in Elderly Subjects Receiving Testosterone or Placebo Treatment (Mean SEM) Treatment groups Test Verbal fluency (number of words produced) Spatial memory immediate recall (number of correct decisions) Spatial memory delayed recall (number of correct decisions) Verbal memory immediate recall (number of recalled pairs) Verbal memory delayed recall (number of recalled pairs) Stroop (interference score: card 3 minus card 2 in seconds) Mental rotation (number of correctly detected flipped items) Before Placebo Before Testosterone Group by interaction 28.5 2.1 34.9 2.1 a 28.1 2.0 30.4 2.3 p.05 17.2 2.0 20.1 1.9 14.9 1.0 15.8 1.4 n.s. 17.1 1.9 19.1 1.8 15.1 1.1 14.8 1.4 n.s. 5.1 0.9 5.7 0.9 3.5 0.7 4.0 0.8 n.s. 6.9 1.0 6.8 1.0 5.1 0.8 4.6 0.9 n.s. 18.9 2.0 16.4 1.0 24.9 3.7 20.3 2.8 n.s. 18.2 1.6 20.9 0.9 13.8 1.2 15.9 1.3 n.s. a p.05 compared to testosterone as well as compared to baseline performance; all n.s. are p.20.

Testosterone and Cognition in Elderly Men BIOL PSYCHIATRY 653 effect in verbal fluency, however, which is typically observed in this task (e.g., Wolf et al 1999) and which occurred in the placebo group. Since testosterone did not influence the practice effect in the Stroop and the mental rotation task, the conclusion seems justified that the effect was specific to verbal fluency and is not the result of a more global effect on procedural learning. Such a negative effect on verbal fluency was not observed by Sih et al (1997) and Cherrier et al (1998), while Janowsky et al (1994) did not measure verbal fluency. Moreover, with the adrenal androgen dehydroepiandrosterone does not impair verbal fluency (Wolf et al 1997, 1998). The current finding supports the hypothesis that male sex steroids can impair performance in tests where women typically outperform men. The present results are in line with a report in female-to-male transsexuals, where the authors observed a decrease in verbal fluency after testosterone (Van Goozen et al 1995). The present study demonstrates that cognitive effects of sex steroids can occur rapidly, which corresponds with other replacement studies from this laboratory (Wolf et al 1998, 1999) as well as with observational studies in younger humans (Kimura and Hampson 1994) and experimental studies in rodents, respectively (McEwen et al 1997). Several reasons for the absence of beneficial effects on memory or mental rotation have to be considered. First, the mental rotation task used in our study differs substantially from those used by other researchers (e.g., Janowsky et al 1994; Kimura and Hampson 1994; Van Goozen et al 1997) since it uses letters and numbers instead of geometric objects. Gender differences are most reliably observed in the mental rotation of geometric figures (like the one developed by Vandenberg and Kuse 1978). If such a task had been used in the present study, the results might have been different. Second, the relationship between testosterone levels and spatial cognition is still discussed as a controversy. Some studies in younger subjects reported a linear relationship between the two (e.g., Christiansen and Knussmann 1987), while other researchers observed a curvilinear relationship when they included men and women into the analysis (Gouchie and Kimura 1991; Moffat and Hampson 1996). The latter studies support Nyborg s theory (Nyborg 1983) that improvements in cognitive performance might only emerge in an optimal (medium) hormone range. This points to the possibility that the testosterone increases induced in the present study might have been too high, since the elderly subjects in the testosterone group had levels 3 times as high as the young control group. Indeed, the only study which reported an enhancement in spatial skills after testosterone tested the subjects directly after application of a new patch, at a time when testosterone levels probably were only slightly elevated and estradiol levels were actually reduced (Janowsky et al 1994). The authors of this experiment suggested that the reduction in estradiol levels might have been the reason for the enhancement in spatial cognition. In our study, as well as in the two other studies which also used testosterone injections rather than patch, estradiol levels rose (as expected) after testosterone (Cherrier et al 1998; Shi et al 1997). This might in part explain the different results obtained. The fact, that testosterone normally increases estradiol levels complicates illumination of the individual contributions of these sex steroids to observed effects. Especially since it is not known if the two hormones have independent effects on cognition, or may act in an antagonistic or synergistic fashion. Third, the short duration in the present experiment might be responsible for the failure to observe beneficial effects on spatial cognition or memory. The two studies that observed cognition enhancing effects of testosterone treated their subjects for 3 weeks (Cherrier et al 1998) or 3 months (Janowsky et al 1994). A third study, failed to find beneficial effects in a 12-month trial (Sih et al 1997). In sum, a single testosterone injection in healthy elderly men blocks the practice effect in verbal fluency without affecting other cognitive domains. Whether this effect is transient or would also be detectable after long-term testosterone remains to be shown in future studies. Beneficial effects on spatial cognition or memory might need more time to develop and/or might only occur when a less pronounced testosterone increase is induced. This study was supported by grants from the Deutsche Forschungsgemeinschaft (Ki 537/6-1 and He 1013/13-1). References Baeumler G (1974): Lern-und Gedaechtnistes (LGT-3): Handanweisung. Goettingen, Germany: Hogrefe. Cherrier M, Asthana S, Plymate S, Baker L, Matsumoto A, Bremner W, et al (1998): Effects of testosterone on cognition in healthy elderly men. Soc Neurosci (Abstracts) 24:2118. Christiansen K, Knussmann R (1987): Sex hormones and cognitive functioning in men. Neuropsychobiology 18:27 36. Gouchie C, Kimura D (1991): The relationship between testosterone levels and cognitive ability patterns. Psychoneuroendocrinology 16:323 334. Hampson E (1995): Spatial cognition in humans: Possible modulation by androgens and estrogens. J Psychiatry Neurosci 20:397 404. Haskell SG, Richardson ED, Horwitz RI (1997): The effect of estrogen replacement therapy on cognitive function in wom-

654 BIOL PSYCHIATRY O.T. Wolf et al en: A critical review of the literature. J Clin Epidemiol 50:1249 1264. Horn W (1983): Leistungspruefsystem (LPS). Goettingen, Germany: Hogrefe. Janowsky JS, Oviatt SK, Orwoll ES (1994): Testosterone influences spatial cognition in older men. Behav Neurosci 108: 325 332. Kimura D, Hampson E (1994): Cognitive pattern in men and women is influenced by fluctuations in sex hormones. Curr Dir Psychol Sci 3:57 61. McEwen BS, Alves SE, Bulloch K, Weiland NG (1997): Ovarian steroids and the brain: Implications for cognition and aging. Neurology 48:S8 15. Moffat SD, Hampson E (1996): A curvilinear relationship between testosterone and spatial cognition in humans: Possible influence of hand preference. Psychoneuroendocrinology 21:323 337. Nyborg H (1983): Spatial ability in men and women: Review and new theory. Adv Behav Res Ther 5:89 140. Oswald WD, Fleischmann UM (1994): Nuernberger Alters Inventar (NAI). Goettingen, Germany: Hogrefe. Phillips SM, Sherwin BB (1992): Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 17:485 495. Rice MS, Graves AB, McCurry SM, Larson EB (1997): Estrogen replacement therapy and cognitive function in postmenopausal women without dementia. Am J Med 103(suppl 3A): 26S 35S. Sherwin BB, Tulandi T (1996): Add-back estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with leiomyomata uteri. J Clin Endocrinol Metab 81:2545 2549. Sih R, Morley JE, Kaiser FE, Perry HMR, Patrick P, Ross C (1997): Testosterone replacement in older hypogonadal men: A 12-month randomized controlled trial. J Clin Endocrinol Metab 82:1661 1667. Sternbach H (1998): Age-associated testosterone decline in men: Clinical issues for psychiatry. Am J Psychiatry 155:1310 1318. Vandenberg SG, Kuse AR (1978): Mental rotations, a group test of three dimensional spatial visualization. Percept Motor Skills 47:599 601. Van Goozen SH, Cohen-Kettenis PT, Gooren LJ, Frijda NH, Van de Poll NE (1995): Gender differences in behaviour: Activating effects of cross-sex hormones. Psychoneuroendocrinology 20:343 363. Vermeulen A (1991): Androgens in the aging male. J Clin Endocrinol Metab 73:221 224. Wolf OT, Kudielka BM, Hellhammer DH, Toerber S, McEwen BS, Kirschbaum C (1999): Two weeks of transdermal estradiol and its effect on memory and mood: Verbal memory changes are associated with the induced eatradiol levels. Psychoneuroendocrinology 24:727 741. Wolf OT, Naumann E, Hellhammer DH, Kirschbaum C (1998): Effects of deyhdroepiandrosterone (DHEA) replacement in elderly men on event related potentials (ERPs), memory and well-being. J Gerontol 53:M385 390. Wolf OT, Neumann O, Hellhammer DH, Geiben AC, Strasburger CJ, Dressendoerfer RA, Pirke KM, Kirschbaum C (1997): Effects of a two-week physiological dehydroepiandrosterone substitution on cognitive performance and wellbeing in healthy elderly women and men. J Clin Endocrinol Metab 82:2363 2367.